ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020
November 17, 2020PharmAbcine Inc. announced that the company will present the final results of the Phase IIa clinical trial of Olinvacimab for rGBM (recurrent glioblastoma multiforme) patients at SNO (Society of Neuro-Oncology) 2020. -
PharmAbcine Signs CMO Contract with Binex
September 17, 2020CDMO Binex to produce olinvacimab at its new 5,000L production line. -
PharmAbcine, SLBio Enter NSCLC Research Pact
August 04, 2020To evaluate olinvacimab and C-005, a 3rd generation of EGFR inhibitor with superior brain-blood-barrier permeability in treating non-small cell lung cancer.
Pharma Sources Insight January 2025
